Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 2 |
2015 | 1 |
2017 | 1 |
2018 | 3 |
2024 | 0 |
PubMed for Bookshelf ID: 4855188
6 results
Results by year
Filters applied: . Clear all
Page 1
Fostamatinib: First Global Approval.
Drugs. 2018 Jun;78(9):959-963. doi: 10.1007/s40265-018-0927-1.
Drugs. 2018.
PMID: 29869203
Review.
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials.
Bussel J, Arnold DM, Grossbard E, Mayer J, Treliński J, Homenda W, Hellmann A, Windyga J, Sivcheva L, Khalafallah AA, Zaja F, Cooper N, Markovtsov V, Zayed H, Duliege AM.
Bussel J, et al.
Am J Hematol. 2018 Jul;93(7):921-930. doi: 10.1002/ajh.25125. Epub 2018 May 15.
Am J Hematol. 2018.
PMID: 29696684
Free PMC article.
Clinical Trial.
Item in Clipboard
Fostamatinib for persistent/chronic adult immune thrombocytopenia.
Newland A, Lee EJ, McDonald V, Bussel JB.
Newland A, et al.
Immunotherapy. 2018 Jan;10(1):9-25. doi: 10.2217/imt-2017-0097. Epub 2017 Oct 2.
Immunotherapy. 2018.
PMID: 28967793
Free article.
Review.
Item in Clipboard
A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist.
Genovese MC, van der Heijde DM, Keystone EC, Spindler AJ, Benhamou C, Kavanaugh A, Fudman E, Lampl K, O'Brien C, Duffield EL, Poiley J, Weinblatt ME.
Genovese MC, et al.
J Rheumatol. 2014 Nov;41(11):2120-8. doi: 10.3899/jrheum.140238. Epub 2014 Sep 15.
J Rheumatol. 2014.
PMID: 25225285
Clinical Trial.
Item in Clipboard
OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy.
Taylor PC, Genovese MC, Greenwood M, Ho M, Nasonov E, Oemar B, Stoilov R, Vencovsky J, Weinblatt M.
Taylor PC, et al.
Ann Rheum Dis. 2015 Dec;74(12):2123-9. doi: 10.1136/annrheumdis-2014-205361. Epub 2014 Jul 29.
Ann Rheum Dis. 2015.
PMID: 25074688
Clinical Trial.
Item in Clipboard
Genetic characterization to improve interpretation and clinical management of hepatotoxicity caused by tyrosine kinase inhibitors.
Spraggs CF, Xu CF, Hunt CM.
Spraggs CF, et al.
Pharmacogenomics. 2013 Apr;14(5):541-54. doi: 10.2217/pgs.13.24.
Pharmacogenomics. 2013.
PMID: 23556451
Review.
Item in Clipboard
Cite
Cite